History
A list of downloadable documents created during development.
Background information
Macular oedema (retinal vein occlusion) - dexamethasone: equality impact assessment
Macular oedema (retinal vein occlusion) - dexamethasone: final appraisal determination
-
Consultee and commentator comments on the ACD
-
Comments on the ACD received from the public through the NICE website
Macular oedema (retinal vein occlusion) - dexamethasone: appraisal consultation
-
Macular oedema (retinal vein occlusion) - dexamethasone: appraisal consultation
-
Macular oedema (retinal vein occlusion) - dexamethasone: evaluation report
-
Macular oedema (retinal vein occlusion) - dexamethasone: manufacturer submissions
-
Macular oedema (retinal vein occlusion) - dexamethasone: clarification letters
-
Macular oedema (retinal vein occlusion) - dexamethasone: non-manufacturer submissions
-
Macular oedema (retinal vein occlusion) - dexamethasone: expert personal statements
-
Macular oedema (retinal vein occlusion) - dexamethasone: evidence review group report